Lipella Pharmaceuticals Inc. (LIPO)
NASDAQ: LIPO · Real-Time Price · USD
2.570
+0.070 (2.80%)
At close: Apr 1, 2025, 4:00 PM
2.454
-0.116 (-4.53%)
After-hours: Apr 1, 2025, 7:55 PM EDT

Lipella Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-5.02-4.62-2.6-1.87-0.06
Upgrade
Depreciation & Amortization
00---
Upgrade
Stock-Based Compensation
0.951.480.750.730.06
Upgrade
Other Operating Activities
--0.01-0.050
Upgrade
Change in Accounts Payable
0.25-0.250.340.02-0.02
Upgrade
Change in Other Net Operating Assets
-0.140.24-0.330.18-0.01
Upgrade
Operating Cash Flow
-3.95-3.15-1.83-0.99-0.03
Upgrade
Capital Expenditures
--0.01---
Upgrade
Investment in Securities
--0.3-0.3-
Upgrade
Investing Cash Flow
--0.010.3-0.3-
Upgrade
Short-Term Debt Issued
--0.28-0.06
Upgrade
Total Debt Issued
--0.28-0.06
Upgrade
Short-Term Debt Repaid
--0.28---
Upgrade
Total Debt Repaid
--0.28---
Upgrade
Net Debt Issued (Repaid)
--0.280.28-0.06
Upgrade
Issuance of Common Stock
2.84-4.962.10.55
Upgrade
Other Financing Activities
-1.61---
Upgrade
Financing Cash Flow
2.841.345.242.10.61
Upgrade
Net Cash Flow
-1.11-1.833.710.810.58
Upgrade
Free Cash Flow
-3.95-3.16-1.83-0.99-0.03
Upgrade
Free Cash Flow Margin
-736.59%-703.85%-994.35%-381.45%-2.97%
Upgrade
Free Cash Flow Per Share
-3.77-4.22-3.61-2.32-0.11
Upgrade
Cash Interest Paid
-0.01---
Upgrade
Levered Free Cash Flow
-3.06-1.52-0.89-0.330.04
Upgrade
Unlevered Free Cash Flow
-3.06-1.51-0.89-0.330.04
Upgrade
Change in Net Working Capital
-0.110.010.01-0.14-0.02
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q